Diagnostic Center | June 15, 2024
Sun Pharma and Moebius Medical present Phase 2b study on MM-II
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Company raises the annual revenue guidance from mid-teens to high teens
Syngene's collaboration with Zoetis started in 2011
Subscribe To Our Newsletter & Stay Updated
